Form 4: NeueHealth Director Matthew Manders Reports Stock Transaction
SEC Form 4
Director Matthew Manders reports a transaction involving NeueHealth, Inc. common stock and restricted stock units.
Summary
- On May 13, 2025, Matthew Manders, a director of NeueHealth, Inc., reported a transaction.
- The transaction involved the disposition of 10,500 shares of common stock and the acquisition of 10,500 restricted stock units.
- Following the transaction, Manders beneficially owns 16,741 shares of common stock.
- The restricted stock units vested on May 13, 2025, and each unit represents a right to receive one share of NeueHealth's common stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing, reflecting standard insider trading reporting. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of earliest transaction and vesting date of restricted stock units. |
| 05/15/2025 | Date of signature for the report. |
Keywords
NeueHealth, Director, Matthew Manders, Stock Transaction, Restricted Stock Units, Common Stock, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.